Association of p53 and mitochondrial gene with chemosensitization by metformin in ovarian cancer

De-Hua Wei; Yan Wang; Hui-Rong Shi

doi:10.18632/oncotarget.22863

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Association of p53 and mitochondrial gene with chemosensitization by metformin in ovarian cancer

De-Hua Wei _, Yan Wang and Hui-Rong Shi

PDF | HTML | How to cite

Oncotarget. 2018; 9:2971-2976. https://doi.org/10.18632/oncotarget.22863

Metrics: PDF 1355 views | HTML 2355 views | ?

Abstract

De-Hua Wei1, Yan Wang1 and Hui-Rong Shi2

1Department of Gynecology, Puyang People's Hospital Affiliated to Xinxiang Medical University, Henan 457000, China

2Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

Correspondence to:

De-Hua Wei, email: [email protected]

Keywords: ovarian cancer; metformin; p53; D-loop region; chemosensitivity

Received: July 05, 2017 Accepted: November 03, 2017 Published: December 02, 2017

ABSTRACT

Objective: This study aims to investigate the association of p53 and D-loop gene with drug resistance and sensitization induced by metformin in ovarian cancer.

Results: Metformin suppresses cells in a time-dependent manner, but the inhibition does not change with the dose of metformin. This suggests that within a certain range of concentration in the body, metformin has a constant inhibitory effect on cells; and the long-term use of metformin yields a better effect.

Conclusions: Metformin enhances the sensitivity of drug-resistant ovarian cancer cells to chemotherapy.

Methods: The third passage cells of 17 cancerous ovarian tissues, which were successfully passaged five times, were used as the study objects; and the SKOV3 cell line was used as the positive control. After three adaptations, cells were cultured for 72 hours in an orthogonal experiment using drugs that were used for adaptation. Then, the inhibitory rate on cells in the experimental group was observed by CCK8 assay, in order to study the sensitization effect of metformin in different chemotherapies of ovarian cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22863

Publication Alerts

Research Papers:

Association of p53 and mitochondrial gene with chemosensitization by metformin in ovarian cancer

Abstract